Type 1 diabetes

Mark A. Atkinson(University of Florida), Aaron W. Michels(University of Colorado Anschutz Medical Campus), George S. Eisenbarth(University of Colorado Health)

The Lancet

July 25, 2013

10.1016/s0140-6736(13)60591-7

Cited by 2,658

Related Papers

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

|The Lancet|2001|1.5k

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

|Diabetes Care|2015|1.2k

The Pathogenesis of Insulin-Dependent Diabetes Mellitus

|New England Journal of Medicine|1994|1.1k

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

|Nature|1993|1.1k

Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis

|Nature Genetics|2020|815